Scherer R, Giebler R, Kampe S, Kox W J
Institut für Anästhesiologie, Universitätsklinikum, GHS Essen, FRG.
Infusionsther Transfusionsmed. 1994 Oct;21(5):310-4. doi: 10.1159/000223000.
The purpose of this study was to investigate the effect of hypertonic (NaCl 7.5%) hydroxyethyl starch (HES 6%, molecular weight 200,000) (HHES) as used for small-volume resuscitation on global coagulation parameters and platelet function.
Randomized, controlled clinical trial.
Intraoperative volume loading after induction of general anesthesia.
27 consecutive patients [mean age 59 (22-76) years, mean body weight 69.8 (46-98) kg] undergoing abdominal surgery were studied.
Global coagulation tests (aPTT: activated partial thromboplastin time; PT: prothrombin time; platelet count; thrombelastography: TEG), platelet aggregation and ATP release were measured before and 10 min after the application of 4 ml.kg-1 of HHES (study group H, n = 14) or HES (control group C, n = 13).
The aPTT was prolonged and platelet count was significantly reduced in both study groups. In contrast to the HES group, clot formation time in the TEG was significantly prolonged and the maximum amplitude was reduced in the HHES group. Furthermore, platelet aggregation was significantly slowed down, whereas ATP release significantly increased in the HHES group.
The changes in global coagulation parameters can be explained by dilutional effects of the infused solution. The hyperosmolar saline compound of the HHES solution obviously contributes to the slowing down of platelet aggregation. Osmotic stress and membrane pleating may aggravate HES-induced changes in membrane fluidity and microviscosity and thus explain this impaired interaction. The increase in ATP release suggests a change in receptor-second messenger interaction for delta granule release.
本研究旨在探讨用于小容量复苏的高渗(7.5%氯化钠)羟乙基淀粉(6%羟乙基淀粉,分子量200,000)(HHES)对整体凝血参数和血小板功能的影响。
随机对照临床试验。
全身麻醉诱导后的术中容量负荷。
对27例连续接受腹部手术的患者[平均年龄59(22 - 76)岁,平均体重69.8(46 - 98)kg]进行了研究。
在输注4 ml·kg-1 HHES(研究组H,n = 14)或羟乙基淀粉(对照组C,n = 13)之前及之后10分钟,测定整体凝血试验(活化部分凝血活酶时间:aPTT;凝血酶原时间:PT;血小板计数;血栓弹力图:TEG)、血小板聚集和ATP释放。
两个研究组的活化部分凝血活酶时间均延长,血小板计数均显著降低。与羟乙基淀粉组相比,HHES组血栓弹力图中的凝血形成时间显著延长,最大振幅降低。此外,HHES组血小板聚集显著减慢,而ATP释放显著增加。
整体凝血参数的变化可以用输注溶液的稀释作用来解释。HHES溶液中的高渗盐成分明显导致血小板聚集减慢。渗透应激和膜褶皱可能会加剧羟乙基淀粉诱导的膜流动性和微粘度变化,从而解释这种相互作用受损的现象。ATP释放增加表明δ颗粒释放的受体 - 第二信使相互作用发生了变化。